{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:32:16Z","timestamp":1782952336890,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82470021"],"award-info":[{"award-number":["82470021"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bronchial challenge testing with methacholine was applied to evaluate and quantify bronchial hyperresponsiveness (BHR) in asthma patients. We aimed to compare the clinical effectiveness between methacholine chloride and methacholine for methacholine challenge testing (MCT) in clinical practice, and investigate the adverse events associated with methacholine chloride.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Patients who received methacholine and inhaled methacholine chloride for MCT were included in this retrospective study. All participants completed pulmonary function tests and MCT between January 2022 and February 2024. The provocative dose of methacholine that results in a 20% fall in FEV\n                      <jats:sub>1<\/jats:sub>\n                      (PD20-FEV\n                      <jats:sub>1<\/jats:sub>\n                      ) was used as quantitative measure of bronchial hyperresponsiveness. The primary outcome of the study was the proportion of positive MCT results and the degree of BHR, while the secondary outcome was the incidence rate of respiratory adverse events during methacholine chloride administration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 17,352 participants were included. In patients with bronchial symptoms, those administrated methacholine chloride for MCT demonstrated a significantly higher percentage of positive results compared with those administrated conventional methacholine (36.7%\n                      <jats:italic>vs.<\/jats:italic>\n                      30.8%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Moreover, PD20-FEV\n                      <jats:sub>1<\/jats:sub>\n                      values were significantly lower in methacholine chloride group than methacholine group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Chest tightness was the most prevalent adverse symptom affecting 30.8% of patients who received methacholine chloride, followed by cough at 27.2%. No serious adverse events were reported in these patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The data indicated that methacholine chloride yielded a higher positive test rate than methacholine in MCT. Given that only mild adverse symptoms of chest tightness and cough were observed, with no serious adverse events reported, it represents a safe and effective alternative for clinical BHR assessment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40001-026-03982-0","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T03:35:10Z","timestamp":1770176110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparing the inhalation of methacholine chloride and methacholine for methacholine challenge testing"],"prefix":"10.1186","volume":"31","author":[{"given":"Meiping","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiling","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"issue":"6","key":"3982_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/s2213-2600(20)30105-3","volume":"8","author":"JB Soriano","year":"2020","unstructured":"Soriano JB, Kendrick PJ, Paulson KR, Gupta V, Abrams EM, Adedoyin RA, et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8(6):585\u201396. https:\/\/doi.org\/10.1016\/s2213-2600(20)30105-3.","journal-title":"Lancet Respir Med"},{"issue":"9","key":"3982_CR2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/s2213-2600(17)30293-x","volume":"5","author":"GBD 2015 Chronic Respiratory Disease Collaborators","year":"2017","unstructured":"GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691\u2013706. https:\/\/doi.org\/10.1016\/s2213-2600(17)30293-x.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"3982_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.jaip.2016.11.030","volume":"5","author":"P Nair","year":"2017","unstructured":"Nair P, Martin JG, Cockcroft DC, et al. Airway hyperresponsiveness in asthma: measurement and clinical relevance. J Allergy Clin Immunol Pract. 2017;5(3):649-59.e2. https:\/\/doi.org\/10.1016\/j.jaip.2016.11.030.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"3982_CR4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01526-2016","author":"AL Coates","year":"2017","unstructured":"Coates AL, Wanger J, Cockcroft DW, et al. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J. 2017. https:\/\/doi.org\/10.1183\/13993003.01526-2016.","journal-title":"Eur Respir J"},{"issue":"3","key":"3982_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/17476348.2019.1568245","volume":"13","author":"DW Cockcroft","year":"2019","unstructured":"Cockcroft DW, Davis BE, Blais CM. Direct bronchoprovocation test methods: history 1945-2018. Expert Rev Respir Med. 2019;13(3):279\u201389. https:\/\/doi.org\/10.1080\/17476348.2019.1568245.","journal-title":"Expert Rev Respir Med"},{"key":"3982_CR6","unstructured":"Food and drug administration. Compilation of CDER NME and New Biologic Approvals 1985\u20132021. https:\/\/www.fda.gov\/media\/135307\/download. Accessed 18 Mar 2024."},{"issue":"12","key":"3982_CR7","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1034\/j.1398-9995.2000.00732.x","volume":"55","author":"M Ferrari","year":"2000","unstructured":"Ferrari M, Olivieri M, Faccini G, Poli A, Balestreri F, Lo Cascio V. Effects of provocholine and methacholine on airway responses. Allergy. 2000;55(12):1204\u20135. https:\/\/doi.org\/10.1034\/j.1398-9995.2000.00732.x.","journal-title":"Allergy"},{"issue":"4","key":"3982_CR8","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1378\/chest.105.4.1095","volume":"105","author":"CB Sherman","year":"1994","unstructured":"Sherman CB, Kern DG, Corwin RW, Andrus B. A clinical and structural comparison of industrial methacholine and provocholine. Chest. 1994;105(4):1095\u20137. https:\/\/doi.org\/10.1378\/chest.105.4.1095.","journal-title":"Chest"},{"key":"3982_CR9","unstructured":"National medical products asdministratio.The information of the drug approval certificate to be received was releasedn On 24 Mar, 2022. https:\/\/www.nmpa.gov.cn\/zwfw\/sdxx\/sdxxyp\/yppjfb\/20220324160221168.html."},{"key":"3982_CR10","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00204-2017","author":"MA Al Sallakh","year":"2017","unstructured":"Al Sallakh MA, Vasileiou E, Rodgers SE, Lyons RA, Sheikh A, Davies GA. Defining asthma and assessing asthma outcomes using electronic health record data: a systematic scoping review. Eur Respir J. 2017. https:\/\/doi.org\/10.1183\/13993003.00204-2017.","journal-title":"Eur Respir J"},{"key":"3982_CR11","doi-asserted-by":"publisher","unstructured":"American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152(3):1107\u20131136. https:\/\/doi.org\/10.1164\/ajrccm.152.3.7663792","DOI":"10.1164\/ajrccm.152.3.7663792"},{"key":"3982_CR12","doi-asserted-by":"publisher","unstructured":"National Health Commission of the People\u2019s Republic of China; Chinese Thoracic Society. Standard technical specifications for\nmethacholine chloride (methacholine) bronchial challenge test (2023). Zhonghua Jie He He Hu Xi Za Zhi. 2024;47(2):101\u2013119. https:\/\/doi.org\/10.3760\/cma.j.cn112147-20231019-00247","DOI":"10.3760\/cma.j.cn112147-20231019-00247"},{"issue":"2","key":"3982_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/occmed\/kqv158","volume":"66","author":"J Borak","year":"2016","unstructured":"Borak J, Lefkowitz RY. Bronchial hyperresponsiveness. Occup Med (Lond). 2016;66(2):95\u2013105. https:\/\/doi.org\/10.1093\/occmed\/kqv158.","journal-title":"Occup Med (Lond)"},{"issue":"5","key":"3982_CR14","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1183\/09031936.00112606","volume":"29","author":"SS An","year":"2007","unstructured":"An SS, Bai TR, Bates JH, et al. Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J. 2007;29(5):834\u201360. https:\/\/doi.org\/10.1183\/09031936.00112606.","journal-title":"Eur Respir J"},{"issue":"1","key":"3982_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1164\/ajrccm.161.1.ats11-99","volume":"161","author":"RO Crapo","year":"2000","unstructured":"Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000;161(1):309\u201329. https:\/\/doi.org\/10.1164\/ajrccm.161.1.ats11-99.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"3982_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.arbres.2022.10.008","volume":"59","author":"MA Romero-Falc\u00f3n","year":"2023","unstructured":"Romero-Falc\u00f3n MA, Medina-Gallardo JF, Lopez-Campos JL, et al. Evaluation of the diagnostic accuracy of non-specific bronchial provocation tests in the diagnosis of asthma: a randomized cross-over study. Arch Bronconeumol. 2023;59(2):76\u201383. https:\/\/doi.org\/10.1016\/j.arbres.2022.10.008.","journal-title":"Arch Bronconeumol"},{"key":"3982_CR17","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01194-2022","author":"LP Boulet","year":"2023","unstructured":"Boulet LP, Boulay M, C\u00f4t\u00e9 A, et al. Airway inflammation and hyperresponsiveness in subjects with respiratory symptoms and normal spirometry. Eur Respir J. 2023. https:\/\/doi.org\/10.1183\/13993003.01194-2022.","journal-title":"Eur Respir J"},{"issue":"2","key":"3982_CR18","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jaip.2019.09.007","volume":"8","author":"R Louis","year":"2020","unstructured":"Louis R, Bougard N, Guissard F, Paulus V, Henket M, Schleich F. Bronchodilation test with inhaled salbutamol versus bronchial methacholine challenge to make an asthma diagnosis: do they provide the same information? J Allergy Clin Immunol Pract. 2020;8(2):618-25.e8. https:\/\/doi.org\/10.1016\/j.jaip.2019.09.007.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"3982_CR19","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/occmed\/kqy122","volume":"68","author":"J Borak","year":"2018","unstructured":"Borak J, Lefkowitz RY, Linde B. Bronchial hyper-responsiveness: a technical update. Occup Med (Lond). 2018;68(8):519\u201322. https:\/\/doi.org\/10.1093\/occmed\/kqy122.","journal-title":"Occup Med (Lond)"},{"issue":"3","key":"3982_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/resp.14416","volume":"28","author":"AL Coates","year":"2023","unstructured":"Coates AL. How does one get around many of the confounding factors influencing the response to methacholine? Respirology. 2023;28(3):204\u20135. https:\/\/doi.org\/10.1111\/resp.14416.","journal-title":"Respirology"},{"issue":"1","key":"3982_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.15036\/arerugi.65.32","volume":"65","author":"H Sagara","year":"2016","unstructured":"Sagara H, Tanaka A, Ohta S, et al. The Safety and efficacy of airway-hyperresponsiveness test for asthma using by SK-1211 (Methacholine Chloride). Arerugi. 2016;65(1):32\u201340. https:\/\/doi.org\/10.15036\/arerugi.65.32.","journal-title":"Arerugi"},{"issue":"3","key":"3982_CR22","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jaci.2006.01.010","volume":"117","author":"RA Covar","year":"2006","unstructured":"Covar RA, Colvin R, Shapiro G, Strunk R. Safety of methacholine challenges in a multicenter pediatric asthma study. J Allergy Clin Immunol. 2006;117(3):709\u201311. https:\/\/doi.org\/10.1016\/j.jaci.2006.01.010.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"3982_CR23","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1183\/09031936.98.11040946","volume":"11","author":"RD Hayes","year":"1998","unstructured":"Hayes RD, Beach JR, Rutherford DM, Sim MR. Stability of methacholine chloride solutions under different storage conditions over a 9 month period. Eur Respir J. 1998;11(4):946\u20138. https:\/\/doi.org\/10.1183\/09031936.98.11040946.","journal-title":"Eur Respir J"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-026-03982-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-03982-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-03982-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T18:06:02Z","timestamp":1770314762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-026-03982-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3982"],"URL":"https:\/\/doi.org\/10.1186\/s40001-026-03982-0","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the ethics committee of the Ethics Board of the Second Affiliated Hospital of Zhejiang University School of Medicine (2023-0875). All subjects provided written informed consent before conducting methacholine challenge testing.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"229"}}